PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1524281
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1524281
Retinal Detachment Diagnostic Market - By Diagnostics (Fundus Photography, Ophthalmoscopy, Digital Retinal Camera), Disease (Rhegmatogenous Retinal Detachment, Exudative, Serous or Secondary Retinal Detachment), End-use - Global Forecast (2024 - 2032)
Global Retinal Detachment Diagnostic Market size will record 6.9% CAGR from 2024 to 2032, driven by technological breakthroughs in diagnostic imaging coupled with increasing awareness about regular eye examinations. Cutting-edge imaging technologies are enabling earlier detection and precise diagnosis, while heightened awareness is encouraging more individuals to undergo screenings, leading to improved patient outcomes. As healthcare systems prioritize preventive care and early intervention, the demand for efficient and accurate retinal detachment diagnostics will surge, fostering the market expansion. For instance, in May 2024, Optomed unveiled the Optomed Aurora AEYE, a handheld AI fundus camera for enabling instant detection of diabetic retinopathy.
The retinal detachment diagnostic industry is divided into diagnostics, disease, end-use, and region.
By disease, the exudative, serous, or secondary retinal detachment segment will experience substantial growth by 2032. This type of detachment, often associated with conditions like age-related macular degeneration and diabetic retinopathy, presents a significant clinical need for accurate diagnosis. Advanced imaging technologies and diagnostic methods customized for identifying and understanding exudative retinal detachments will fuel the segment expansion.
In terms of end-use, the retinal detachment diagnostic market from the ophthalmic clinics segment will achieve considerable share by 2032 due to its specialized expertise and comprehensive diagnostic capabilities. Equipped with state-of-the-art imaging technologies and staffed by experienced ophthalmologists, these clinics offer an accurate and timely diagnosis of retinal detachment. Patients also prefer the specialized care provided by ophthalmic clinics, Additionally, collaborations with healthcare networks and referral systems are enhancing their accessibility and prominence in delivering efficient retinal detachment diagnostic services.
Europe retinal detachment diagnostic market will exhibit a noteworthy CAGR during 2024-2032, led by robust healthcare infrastructure, the rising prevalence of retinal disorders, and technological advancements. Moreover, government initiatives supporting early diagnosis and treatment will further bolster the market expansion. With emphasis on healthcare innovation and accessibility, Europe will emerge as a key contributor to the industry.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing incidence of retinal detachment
- 3.2.1.2 Rising geriatric population
- 3.2.1.3 Technological advancements in ophthalmic diagnostic instruments
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Lack of trained ophthalmologist in developing regions
- 3.2.2.2 High cost of devices
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Technology landscape
- 3.5 Future market trends
- 3.6 Regulatory landscape
- 3.7 Porter's analysis
- 3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Diagnostics, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Digital retinal camera
- 5.3 Fundus photography
- 5.4 Ophthalmoscopy
- 5.5 Fluorescent retinal angiography
- 5.6 Other diagnostics
Chapter 6 Market Estimates and Forecast, By Disease, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Rhegmatogenous retinal detachment
- 6.3 Exudative, serous, or secondary retinal detachment
- 6.4 Tractional retinal detachment
Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Hospitals
- 7.3 Ophthalmic clinics
- 7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
- 9.1 Canon Medical Systems Corporation
- 9.2 Carl Zeiss Meditec AG
- 9.3 Centervue SpA.
- 9.4 Essilor International
- 9.5 Eyenuk Inc.
- 9.6 HealPros LLC
- 9.7 Millennium Surgical Corp.
- 9.8 ONL Therapeutics
- 9.9 Peek Vision Ltd
- 9.10 Synergy Medical Systems LLP
